Metastatic Hepatocellular Carcinoma Recruiting Phase 1 Trials for Cyclophosphamide (DB00531)

Also known as: Hepatocellular Carcinoma Metastatic / Metastatic hepatocellular carcinoma (morphologic abnormality) / Hepatocellular carcinoma / Carcinoma hepatocellular / Hepatoma / Primary carcinoma of liver (disorder) / Liver carcinoma / (Liver carcinoma) or (Ca: [liver/biliary system] or [biliary system]) / Carcinoma liver / Liver cell carcinoma (disorder) / Hepatocellular carcinoma (morphologic abnormality) / Carcinoma of liver / Carcinoma, Hepatocellular

IndicationStatusPhase
DBCOND0041971 (Metastatic Hepatocellular Carcinoma)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05269381Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid TumorsTreatment
NCT05003895GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Hepatocellular Carcinoma (HCC)Treatment
NCT05075993Study of LVGN3616 and LVGN6051┬▒LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid TumorsTreatment